The Morning Run speaks to Dodge about potential impeachment impact on markets, locking in gains as we get closer to the trade deadline as well as Dodge's asset allocation strategy for 2020. We also ask him about the consolidation in the pharmaceutical and biotechnology space and whether Dodge will be getting in on the Aramco's listing. 

<p>The Morning Run speaks to Dodge about potential impeachment impact on markets, locking in gains as we get closer to the trade deadline as well as Dodge's asset allocation strategy for 2020. We also ask him about the consolidation in the pharmaceutical and biotechnology space and whether Dodge will be getting in on the Aramco's listing.&nbsp;</p>

Dovish or hawkish? Over or underweight? Bull or Bear? Investor paralysis? We speak to leading local and foreign analyst to find out how the different asset classes and markets will react to the latest news, results and even geopolitical events.

<p>Dovish or hawkish? Over or underweight? Bull or Bear? Investor paralysis? We speak to leading local and foreign analyst to find out how the different asset classes and markets will react to the latest news, results and even geopolitical events.</p>

Advertisement